Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
Quyuan Tao, Jiaxin Du, Xiantao Li, et al.
Drug Development and Industrial Pharmacy (2020) Vol. 46, Iss. 8, pp. 1345-1353
Open Access | Times Cited: 192

Showing 26-50 of 192 citing articles:

Organoids and Organ-On-Chip Models for COVID-19 Research and its Application in Modernization of Traditional Chinese Medicine: Opportunities and Challenges
Hongda Sheng, Yanchun Liang, Volker M. Lauschke, et al.
Engineering (2025)
Open Access
Network pharmacology and molecular docking to reveal the pharmacological mechanisms of Abelmoschus esculentus (l.) moench in treating breast cancer
I. E. Otuokere, J. I. Iheanyichukwu, O. M. Mac-kalunta, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Network Pharmacology Integrated Docking Studies on Molecular Targets of Achyranthes aspera in the Treatment of Rheumatoid Arthritis
Sivasankari Marimuthu, Arul Jayanthi Antonisamy, Janani Palpandi, et al.
Biomedical and Biotechnology Research Journal (BBRJ) (2025) Vol. 9, Iss. 1, pp. 41-47
Open Access
Artemether, Artesunate, Arteannuin B, Echinatin, Licochalcone B and Andrographolide Effectively Inhibit SARS-CoV-2 and Related Viruses In Vitro
Yunjia Hu, Meiqin Liu, Hongbo Qin, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 38
Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes)
Evgeni Gusev, Alexey Sarapultsev, Desheng Hu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7582-7582
Open Access | Times Cited: 36
Systems Pharmacology Study of the Anti-Liver Injury Mechanism of Citri Reticulatae Pericarpium
Jianxiong Wu, Xietao Ye, Songhong Yang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34
Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources
Rajeev K. Singla, Xuefei He, Hitesh Chopra, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34
Exploration of the mechanism of luteolin against ischemic stroke based on network pharmacology, molecular docking and experimental verification
Rui Dong, Renxuan Huang, Xiaohua Shi, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 12274-12293
Open Access | Times Cited: 34
Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 Treatment
Ke-Yao Xia, Zeyuan Zhao, Taif Shah, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
Network Pharmacology and Molecular Docking-Based Mechanism Study to Reveal the Protective Effect of Salvianolic Acid C in a Rat Model of Ischemic Stroke
Yuting Yang, Yu He, Xiaoyu Wei, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
Xuanfei Baidu decoction attenuates intestinal disorders by modulating NF-κB pathway, regulating T cell immunity and improving intestinal flora
Lin Ma, Xin Zhao, Tao Liu, et al.
Phytomedicine (2022) Vol. 101, pp. 154100-154100
Closed Access | Times Cited: 26
Oral Chinese Herbal Medicine on Immune Responses During Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
Shihua Shi, Fei Wang, Huan Yao, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 23
New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches
Kexin Jia, Yijie Li, Tiegang Liu, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 157-168
Open Access | Times Cited: 13
Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by network pharmacology and molecular docking
Lv Y, Zhonghao Liu, Leihong Deng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Potential Treatment of COVID-19 with Traditional Chinese Medicine: What Herbs Can Help Win the Battle with SARS-CoV-2?
Lin Li, Yuzheng Wu, Jiabao Wang, et al.
Engineering (2021) Vol. 19, pp. 139-152
Open Access | Times Cited: 30
Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical Trial
Zhao Chen, Li Li, Wei Yang, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 28
Prevention, treatment and potential mechanism of herbal medicine for Corona viruses: A review
Yanxia Liu, Yanhe Zhou, Chang-Hong Jiang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 5480-5508
Open Access | Times Cited: 20
Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19
Shihao Zheng, Tianyu Xue, Bin Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID‐19 by dual binding to IL-6/STAT3
Weikang Luo, Ruoqi Ding, Xiaohang Guo, et al.
Computers in Biology and Medicine (2022) Vol. 145, pp. 105457-105457
Open Access | Times Cited: 19
Traditional Chinese Medicines Against COVID-19
Chang-Liang Yao, Wenlong Wei, Jian-Qing Zhang, et al.
World Journal of Traditional Chinese Medicine (2022) Vol. 8, Iss. 3, pp. 279-313
Open Access | Times Cited: 19
Research and development of Chinese anti-COVID-19 drugs
Xiwei Ji, Xiangrui Meng, Xiao Zhu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4271-4286
Open Access | Times Cited: 19
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-70
Open Access | Times Cited: 18
Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing
Md. Ariful Islam, Md. Kaderi Kibria, Md. Bayazid Hossen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Role of Network Pharmacology in Prediction of Mechanism of Neuroprotective Compounds
Saima Saima, S. Latha, Ruchika Sharma, et al.
Methods in molecular biology (2024), pp. 159-179
Closed Access | Times Cited: 3
Study on the mechanism of quercetin in Sini Decoction Plus Ginseng Soup to inhibit liver cancer and HBV virus replication through CDK1
Liyuan Hao, Shenghao Li, Guo Chen, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 3

Scroll to top